Mirtaza Tablets 30 mg 30 is a medicine registered with the Saudi Food and Drug Authority. It contains the active ingredient Mirtazapine 30 mg, and its pharmaceutical form is tablet. This medicine is available on prescription only.
Medicine Details
- Registered Trade Name: MIRTAZA 30 mg film-coated tablet
- Active Ingredient and Strength: Mirtazapine 30 mg
- Pharmaceutical Form: Tablet
- Route of Administration: Oral
- Marketing Authorisation Holder: APOTEX INC. (SIGNET SITE) (Canada)
- ATC Classification Code: N06AX11
Prescription Requirement
This medicine is dispensed only against a valid prescription from a licensed doctor. When ordering from the store, upload a prescription image for the pharmacist to review before preparing the order. The dose and duration of use are determined solely by the treating doctor.
Storage
Store at room temperature not exceeding 30 degrees Celsius. Keep out of reach of children.
Registration Information
Registered with the Saudi Food and Drug Authority under number 2609222644.
The information above provides identification details from the Saudi Food and Drug Authority register and does not replace the treating doctor's instructions, the patient leaflet, or consultation with a pharmacist.